Ionis Announces Submission of Marketing Authorization Application for Inotersen to the EMA Post author:Sam Post published:November 2, 2017 Post category:BioPharma The MAA will be reviewed under the EMA’s Accelerated Assessment program. Source: BioSpace You Might Also Like 8 PDUFA Dates to Watch in August July 31, 2017 Johnson & Johnson Dissolves $700 Million R&D Deal With MacroGenics August 31, 2017 OTraces Release: Beyond Liquid Biopsy: Blood Test Can Boost Cancer Detection, Diagnosis With the Tumor Microenvironment (TME), Early Validation Results Reveal (White Paper) June 15, 2017
OTraces Release: Beyond Liquid Biopsy: Blood Test Can Boost Cancer Detection, Diagnosis With the Tumor Microenvironment (TME), Early Validation Results Reveal (White Paper) June 15, 2017
